Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

Jeanne Whalen writes about the U.S. economy from the Chicago bureau. She previously covered healthcare, general news and ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

Clinical-stage company targeting fundamental drivers of inflammation, autoimmunity and fibrosis, founded by Versant Ventures and Novartis Venture Fund- ...

This expands the previous authorization for individuals aged 60 and older, and ABRYSVO now of ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with ...

GlaxoSmithKline was formerly called ... Norwich Union and CGU plc, and is the 14th largest insurance company in the world. British American Tobacco is the world’s 2nd largest cigarette ...

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

Zevra Continues Growth Trajectory into a Global Commercial Rare Disease Company with Consistent Execution, New Product ...

Immediate resistance for the benchmark Nifty 50 Index is seen at 24545, while Support for the Nifty has shifted upwards to ...